Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease

被引:21
作者
Balcerzyk, Anna
Zak, Iwona
Krauze, Jolanta
机构
[1] L Warynski Silesian Med Acad, Dept Biochem & Med Genet, PL-40752 Katowice, Poland
[2] L Warynski Silesian Med Acad, Dept Cardiol 1, PL-40752 Katowice, Poland
关键词
coronary artery disease; polymorphism; PPARA; ABCAI;
D O I
10.2143/AC.62.3.2020810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Progression of atherosclerosis, the main reason of cardiovascular diseases, depends on multiple genetic and environmental factors. Polymorphic variants of genes involved in the lipids metabolism may genetically differentiate human populations and determine a susceptibility to the disease. The aim of the present study was to evaluate a possible interaction between R219K polymorphism of ABCA1 gene and G > C polymorphism in intron 7 of PPARA gene in determining the risk of the CAD. Methods - We studied 358 subjects: 178 patients with angiographically confirmed CAD and 180 blood donors without history of CAD. Polymorphisms were genotyped using the PCR-RFLP method. Results - In spite of a small or no correlation between single polymorphism and CAD we observed that the frequencies of AA+GC,CC genotype pattern (ABCA1 and PPARA gene) were significantly higher in CAD group than in controls. OR values were especially high in multiple logistic regression and were higher for male subgroups. The synergy index value equals 3.98 and indicates a quite strong synergistic effect between the analysed polymorphisms. We also observed that C allele carriers of PPARA gene had a significantly lower total and LDL-cholesterol level. Conclusion - The present study shows that R219K polymorphism of ABCA1 gene and G>C polymorphism in intron 7 of PPARA gene act cumulatively and synergistically in determining the risk of premature CAD.
引用
收藏
页码:233 / 238
页数:6
相关论文
共 16 条
[1]   Myocardial infarction redefined -: A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Hoppe, U ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
de Werf, FV ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
EUROPEAN HEART JOURNAL, 2000, 21 (18) :1502-1513
[2]  
Attie AD, 2001, J LIPID RES, V42, P1717
[3]   LIPIDS AND OXIDIZED LIPIDS IN HUMAN ATHEROSCLEROTIC LESIONS AT DIFFERENT STAGES OF DEVELOPMENT [J].
CARPENTER, KLH ;
TAYLOR, SE ;
VANDERVEEN, C ;
WILLIAMSON, BK ;
BALLANTINE, JA ;
MITCHINSON, MJ .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1256 (02) :141-150
[4]  
Clee SM, 2001, CIRCULATION, V103, P1198
[5]   HDL-cholesterol as a marker of coronary heart disease risk:: the Quebec cardiovascular study [J].
Després, JP ;
Lemieux, I ;
Dagenais, GR ;
Cantin, B ;
Lamarche, B .
ATHEROSCLEROSIS, 2000, 153 (02) :263-272
[6]   The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia [J].
Evans, D ;
Beil, FU .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (04) :264-270
[7]   Peroxisome proliferator-activated receptor α gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease [J].
Flavell, DM ;
Jamshidi, Y ;
Hawe, E ;
Torra, LP ;
Taskinen, MR ;
Frick, MH ;
Nieminen, MS ;
Kesäniemi, YA ;
Pasternack, A ;
Staels, B ;
Miller, G ;
Humphries, SE ;
Talmud, PJ ;
Syvänne, M .
CIRCULATION, 2002, 105 (12) :1440-1445
[8]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[9]  
Khoury MJ, 1996, AM J EPIDEMIOL, V144, P207
[10]   ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells [J].
Reddy, ST ;
Hama, S ;
Ng, C ;
Grijalva, V ;
Navab, M ;
Fogelman, AM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (11) :1877-1883